Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-08

Clinical Trial Update: Comparison of Hyperbaric Prilocaine 2% 50 Mg and Hyperbaric Bupivacaine 0.5% 12.5 Mg Against Spinal Anesthesia Recovery Time in Cystoscopy Procedure [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing hyperbaric prilocaine 2% 50 mg versus hyperbaric bupivacaine 0.5% 12.5 mg for spinal anesthesia recovery time in cystoscopy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyperbaric bupivacaine 0.5% 12.5 mg (bupivacaine)
  • Hyperbaric prilocaine 2% 50 mg (prilocaine)

Snippet

Sponsor: Indonesia University | Conditions: Anesthesia, Anesthesia; Reaction | Phase 4 | Status: UNKNOWN